Radiation risk of mammography related to benefit in screening programmes: a favourable balance?

Objectives To estimate the number of breast cancer deaths induced by low dose radiation in breast cancer screening programmes compared with numbers prevented. Methods A computer simulation model on the natural history of breast cancer was combined with a model from BEIR-V on induced breast cancer mortality from low levels of radiation. The improvement in prognosis resulting from screening was based on the results of the Swedish overview of the randomised screening trials for breast cancer and the performance of screening in the Netherlands. Different scenarios (ages and intervals) were used to explore the objectives. Sensitivity analyses were carried out for latency period, dose of mammography, sensitivity of the screening test, early detection by screening of induced breast tumours, and new 1996 risk estimates by Howe and McLaughlin. Results For a screening programme, age group 50–69, two year interval, 2 mGy per view, the balance between the number of deaths induced versus those prevented was favourable: 1:242. When screening is expanded to the age group 40–49 with a one or two year interval the results may be less favourable, that is, 1:66 and 1:97. According to these scenarios and with the Dutch scenario as reference, one breast cancer death from radiation may be expected to occur to save eight extra deaths from breast cancer. If screening was equally effective in young women as in women aged 50–69, the marginal value was 1:±30. Assuming detection of induced cancers by screening could influence the ratios by about 30%, but did not substantially change the conclusions. The new risk estimates by Howe and McLaughlin resulted in five times to eight times favourable ratios breast cancer deaths induced to prevented. Besides age group of screening, dose of mammography is the other determinant of risk. Conclusions For screening under the age of 50, the balance between the number of breast cancer deaths prevented by screening compared with the number induced by radiation seem less favourable. Credibility intervals were however wide, because of many uncertainties of radiation risk at very low doses.

[1]  G. Barnes,et al.  Spectral dependence of glandular tissue dose in screen-film mammography. , 1991, Radiology.

[2]  R. Monson,et al.  Breast cancer after multiple chest fluoroscopies: second follow-up of Massachusetts women with tuberculosis. , 1989, Cancer research.

[3]  P. Cross.  Doses in mammography: from the phantom to the patient. , 1994, Australasian radiology.

[4]  H. D. de Koning,et al.  Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. , 1995, Journal of the National Cancer Institute.

[5]  J. Law.  Risk and benefit associated with radiation dose in breast screening programmes--an update. , 1995, The British journal of radiology.

[6]  C. Land,et al.  Incidence of female breast cancer among atomic bomb survivors, 1950-1985. , 1994, Radiation research.

[7]  J D Habbema,et al.  A model for breast cancer screening , 1990, Cancer.

[8]  H. Kato,et al.  Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86). , 1990, Radiation research.

[9]  D. Pierce,et al.  Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses. , 1989, Radiation research.

[10]  J Law.  Patient dose and risk in mammography. , 1991, The British journal of radiology.

[11]  K. Young,et al.  Dose and image quality in mammography with an automatic beam quality system. , 1996, The British journal of radiology.

[12]  H. D. de Koning,et al.  Prediction of the effects and costs of breast‐cancer screening in Germany , 1994, International journal of cancer.

[13]  J. Palmgren,et al.  Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease. , 1995, British Journal of Cancer.

[14]  J. Hendriks,et al.  REDUCTION OF BREAST CANCER MORTALITY THROUGH MASS SCREENING WITH MODERN MAMMOGRAPHY First Results of the Nijmegen Project, 1975 - 1981 , 1984, The Lancet.

[15]  C. Land.  Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer. , 1995, JAMA.

[16]  K C Young,et al.  Mammographic film density and detection of small breast cancers. , 1994, Clinical radiology.

[17]  B. Pasternack,et al.  Breast cancer among women given X-ray therapy for acute postpartum mastitis. , 1986, Journal of the National Cancer Institute.

[18]  A. Hercbergs,et al.  Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease. , 1994, Journal of the National Cancer Institute.

[19]  N. Day,et al.  EVALUATION OF SCREENING FOR BREAST CANCER IN A NON-RANDOMISED STUDY (THE DOM PROJECT) BY MEANS OF A CASE-CONTROL STUDY , 1984, The Lancet.

[20]  G R Howe,et al.  Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. , 1995, Radiation research.

[21]  H. D. de Koning,et al.  Nation‐wide breast cancer screening in the Netherlands: Support for breast‐cancer mortality reduction , 1995, International journal of cancer.

[22]  H A Risch,et al.  Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. , 1989, The New England journal of medicine.